α-Synuclein expression in the brain and blood during abstinence from chronic alcohol drinking in mice

Neuropharmacology

Volumn 54, Issue 8, 2008, Pages 1239-1246

  Ziolkowska, Barbara ^a   Gieryk, Agnieszka ^a   Wawrzczak Bargiela, Agnieszka ^a   Krowka, Tomasz ^a   Kaminska, Dorota ^a   Korkosz, Agnieszka ^b   Bienkowski, Przemyslaw ^b   Przewlocki, Ryszard ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Synuclein; Abstinence; Alcohol drinking; Amygdala; Craving; Two bottle choice

Indexed keywords

ALPHA SYNUCLEIN;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; IMAGE ANALYSIS; IN SITU HYBRIDIZATION; MALE; MESENCEPHALON; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SUBSTANTIA NIGRA; UPREGULATION; VENTRAL TEGMENTUM; WESTERN BLOTTING;

ALCOHOL DRINKING; ALPHA-SYNUCLEIN; ANIMALS; BLOTTING, WESTERN; BRAIN; BRAIN CHEMISTRY; IMAGE PROCESSING, COMPUTER-ASSISTED; IN SITU HYBRIDIZATION; MALE; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 43949131038     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.04.001     Document Type: Article

References (55)

1. Abeliovich A., Schmitz Y., Farinas I., Choi-Lundberg D., Ho W.H., Castillo P.E., Shinsky N., Verdugo J.M., Armanini M., Ryan A., Hynes M., Phillips H., Sulzer D., and Rosenthal A. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25 (2000) 239-252
2. Acquas E., Carboni E., and Di Chiara G. Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats. European Journal of Pharmacology 193 (1991) 133-134
3. Aston-Jones G., and Harris G.C. Brain substrates for increased drug seeking during protracted withdrawal. Neuropharmacology 47 Suppl. 1 (2004) 167-179
4. Baptista M.J., O'Farrell C., Daya S., Ahmad R., Miller D.W., Hardy J., Farrer M.J., and Cookson M.R. Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines. Journal of Neurochemistry 85 (2003) 957-968
5. Bonsch D., Reulbach U., Bayerlein K., Hillemacher T., Kornhuber J., and Bleich S. Elevated alpha synuclein mRNA levels are associated with craving in patients with alcoholism. Biological Psychiatry 56 (2004) 984-986
6. Bonsch D., Greifenberg V., Bayerlein K., Biermann T., Reulbach U., Hillemacher T., Kornhuber J., and Bleich S. Alpha-synuclein protein levels are increased in alcoholic patients and are linked to craving. Alcoholism, Clinical and Experimental Research 29 (2005) 763-765
7. Bonsch D., Lederer T., Reulbach U., Hothorn T., Kornhuber J., and Bleich S. Joint analysis of the NACP-REP1 marker within the alpha synuclein gene concludes association with alcohol dependence. Human Molecular Genetics 14 (2005) 967-971
8. Bonson K.R., Grant S.J., Contoreggi C.S., Links J.M., Metcalfe J., Weyl H.L., Kurian V., Ernst M., and London E.D. Neural systems and cue-induced cocaine craving. Neuropsychopharmacology 26 (2002) 376-386
9. Borlikova G.G., Le Merrer J., and Stephens D.N. Previous experience of ethanol withdrawal increases withdrawal-induced c-fos expression in limbic areas, but not withdrawal-induced anxiety and prevents withdrawal-induced elevations in plasma corticosterone. Psychopharmacology (Berlin) 185 (2006) 188-200
10. Brenz Verca M.S., Bahi A., Boyer F., Wagner G.C., and Dreyer J.L. Distribution of alpha- and gamma-synucleins in the adult rat brain and their modification by high-dose cocaine treatment. European Journal of Neuroscience 18 (2003) 1923-1938
11. Chan A.W., Leong F.W., Schanley D.L., Langan M.C., and Penetrante F. Flumazenil (Ro15-1788) does not affect ethanol tolerance and dependence. Pharmacology, Biochemistry, and Behavior 39 (1991) 659-663
12. Childress A.R., Mozley P.D., McElgin W., Fitzgerald J., Reivich M., and O'Brien C.P. Limbic activation during cue-induced cocaine craving. American Journal of Psychiatry 156 (1999) 11-18
13. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162 (1987) 156-159
14. Ciccocioppo R., Sanna P.P., and Weiss F. Cocaine-predictive stimulus induces drug-seeking behavior and neural activation in limbic brain regions after multiple months of abstinence: reversal by D(1) antagonists. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 1976-1981
15. Clayton D.F., and George J.M. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends in Neurosciences 21 (1998) 249-254
16. Clayton D.F., and George J.M. Synucleins in synaptic plasticity and neurodegenerative disorders. Journal of Neuroscience Research 58 (1999) 120-129
17. Couceyro P., and Douglass J. Precipitated morphine withdrawal stimulates multiple activator protein-1 signaling pathways in rat brain. Molecular Pharmacology 47 (1995) 29-39
18. Diana M., Pistis M., Carboni S., Gessa G.L., and Rossetti Z.L. Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence. Proceedings of the National Academy of Sciences of the United States of America 90 (1993) 7966-7969
19. Fornai F., Lenzi P., Ferrucci M., Lazzeri G., di Poggio A.B., Natale G., Busceti C.L., Biagioni F., Giusiani M., Ruggieri S., and Paparelli A. Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice. Brain Research Bulletin 65 (2005) 405-413
20. Foroud T., Wetherill L.F., Liang T., Dick D.M., Hesselbrock V., Kramer J., Nurnberger J., Schuckit M., Carr L., Porjesz B., Xuei X., and Edenberg H.J. Association of alcohol craving with alpha-synuclein (SNCA). Alcoholism, Clinical and Experimental Research 31 (2007) 537-545
21. Freedman L.J., and Cassell M.D. Distribution of dopaminergic fibers in the central division of the extended amygdala of the rat. Brain Research 633 (1994) 243-252
22. Frenois F., Cador M., Caille S., Stinus L., and Le Moine C. Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal. European Journal of Neuroscience 16 (2002) 1377-1389
23. Gracy K.N., Dankiewicz L.A., and Koob G.F. Opiate withdrawal-induced Fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion. Neuropsychopharmacology 24 (2001) 152-160
24. He X.X., Nebert D.W., Vasiliou V., Zhu H., and Shertzer H.G. Genetic differences in alcohol drinking preference between inbred strains of mice. Pharmacogenetics 7 (1997) 223-233
25. Hong L., Ko H.W., Gwag B.J., Joe E., Lee S., Kim Y.T., and Suh Y.H. The cDNA cloning and ontogeny of mouse alpha-synuclein. Neuroreport 9 (1998) 1239-1243
26. Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., de Silva H.A., Kittel A., and Saitoh T. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14 (1995) 467-475
27. Knapp D.J., Duncan G.E., Crews F.T., and Breese G.R. Induction of Fos-like proteins and ultrasonic vocalizations during ethanol withdrawal: further evidence for withdrawal-induced anxiety. Alcoholism, Clinical and Experimental Research 22 (1998) 481-493
28. Korkosz A., Kolomanska P., Kowalska K., Rogowski A., Radwanska K., Kaczmarek L., Mierzejewski P., Scinska A., Kostowski W., and Bienkowski P. Dissociation of ethanol and saccharin preference in fosB knockout mice. Physiology and Behavior 82 (2004) 391-395
29. Larsen K.E., Schmitz Y., Troyer M.D., Mosharov E., Dietrich P., Quazi A.Z., Savalle M., Nemani V., Chaudhry F.A., Edwards R.H., Stefanis L., and Sulzer D. Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. Journal of Neuroscience 26 (2006) 11915-11922
30. Lee F.J., Liu F., Pristupa Z.B., and Niznik H.B. Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. FASEB Journal 15 (2001) 916-926
31. Liang T., Spence J., Liu L., Strother W.N., Chang H.W., Ellison J.A., Lumeng L., Li T.K., Foroud T., and Carr L.G. Alpha-synuclein maps to a quantitative trait locus for alcohol preference and is differentially expressed in alcohol-preferring and -nonpreferring rats. Proceedings of the National Academy of Sciences of the United States of America 100 (2003) 4690-4695
32. Lotharius J., and Brundin P. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nature Reviews Neuroscience 3 (2002) 932-942
33. Markou A., Kosten T.R., and Koob G.F. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 18 (1998) 135-174
34. Maroteaux L., and Scheller R.H. The rat brain synucleins; family of proteins transiently associated with neuronal membrane. Molecular Brain Research 11 (1991) 335-343
35. Marti M.J., Tolosa E., and Campdelacreu J. Clinical overview of the synucleinopathies. Movement Disorders 18 Suppl. 6 (2003) S21-S27
36. Mash D.C., Ouyang Q., Pablo J., Basile M., Izenwasser S., Lieberman A., and Perrin R.J. Cocaine abusers have an overexpression of alpha-synuclein in dopamine neurons. Journal of Neuroscience 23 (2003) 2564-2571
37. McDonald A.J. Topographical organization of amygdaloid projections to the caudatoputamen, nucleus accumbens, and related striatal-like areas of the rat brain. Neuroscience 44 (1991) 15-33
38. Nakajo S., Shioda S., Nakai Y., and Nakaya K. Localization of phosphoneuroprotein 14 (PNP 14) and its mRNA expression in rat brain determined by immunocytochemistry and in situ hybridization. Molecular Brain Research 27 (1994) 81-86
39. Oksman M., Tanila H., and Yavich L. Brain reward in the absence of alpha-synuclein. Neuroreport 17 (2006) 1191-1194
40. Panagis G., Hildebrand B.E., Svensson T.H., and Nomikos G.G. Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome. Synapse 35 (2000) 15-25
41. Pandey S.C. Anxiety and alcohol abuse disorders: a common role for CREB and its target, the neuropeptide Y gene. Trends in Pharmacological Sciences 24 (2003) 456-460
42. Peirce J.L., Derr R., Shendure J., Kolata T., and Silver L.M. A major influence of sex-specific loci on alcohol preference in C57Bl/6 and DBA/2 inbred mice. Mammalian Genome 9 (1998) 942-948
43. Perez R.G., Waymire J.C., Lin E., Liu J.J., Guo F., and Zigmond M.J. A role for alpha-synuclein in the regulation of dopamine biosynthesis. Journal of Neuroscience 22 (2002) 3090-3099
44. Qin Y., Ouyang Q., Pablo J., and Mash D.C. Cocaine abuse elevates alpha-synuclein and dopamine transporter levels in the human striatum. Neuroreport 16 (2005) 1489-1493
45. Rodriguez de Fonseca F., Carrera M.R., Navarro M., Koob G.F., and Weiss F. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276 (1997) 2050-2054
46. Schneider F., Habel U., Wagner M., Franke P., Salloum J.B., Shah N.J., Toni I., Sulzbach C., Honig K., Maier W., Gaebel W., and Zilles K. Subcortical correlates of craving in recently abstinent alcoholic patients. American Journal of Psychiatry 158 (2001) 1075-1083
47. Shalev U., Grimm J.W., and Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacological Reviews 54 (2002) 1-42
48. Swanson L.W. The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Research Bulletin 9 (1982) 321-353
49. Vekrellis K., Rideout H.J., and Stefanis L. Neurobiology of alpha-synuclein. Molecular Neurobiology 30 (2004) 1-21
50. Walker S.J., and Grant K.A. Peripheral blood alpha-synuclein mRNA levels are elevated in cynomolgus monkeys that chronically self-administer ethanol. Alcohol 38 (2006) 1-4
51. Wersinger C., and Sidhu A. Attenuation of dopamine transporter activity by alpha-synuclein. Neuroscience Letters 340 (2003) 189-192
52. Yavich L., Tanila H., Vepsalainen S., and Jakala P. Role of alpha-synuclein in presynaptic dopamine recruitment. Journal of Neuroscience 24 (2004) 11165-11170
53. Young III W.S., Bonner T.I., and Brann M.R. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proceedings of the National Academy of Sciences of the United States of America 83 (1986) 9827-9831
54. Zhu W., and Pan Z.Z. Synaptic properties and postsynaptic opioid effects in rat central amygdala neurons. Neuroscience 127 (2004) 871-879
55. Ziolkowska B., Gieryk A., Bilecki W., Wawrzczak-Bargiela A., Wedzony K., Chocyk A., Danielson P.E., Thomas E.A., Hilbush B.S., Sutcliffe J.G., and Przewlocki R. Regulation of alpha-synuclein expression in limbic and motor brain regions of morphine-treated mice. Journal of Neuroscience 25 (2005) 4996-5003